80 related articles for article (PubMed ID: 21393873)
1. Clinicopathologic significance of fascin, extracellular matrix metalloproteinase inducer, and ezrin expressions in colorectal adenocarcinoma.
Jung EJ; Lee JH; Min BW; Kim YS; Choi JS
Indian J Pathol Microbiol; 2011; 54(1):32-6. PubMed ID: 21393873
[TBL] [Abstract][Full Text] [Related]
2. EMMPRIN and fascin overexpression associated with clinicopathologic parameters of pancreatobiliary adenocarcinoma in Chinese people.
Tsai WC; Chao YC; Sheu LF; Lin YF; Nieh S; Chen A; Yu CP; Jin JS
APMIS; 2007 Aug; 115(8):929-38. PubMed ID: 17696949
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
5. High extracellular matrix metalloproteinase inducer/CD147 expression is strongly and independently associated with poor prognosis in colorectal cancer.
Stenzinger A; Wittschieber D; von Winterfeld M; Goeppert B; Kamphues C; Weichert W; Dietel M; Rabien A; Klauschen F
Hum Pathol; 2012 Sep; 43(9):1471-81. PubMed ID: 22417846
[TBL] [Abstract][Full Text] [Related]
6. Aberrant expression of cortactin and fascin are effective markers for pathogenesis, invasion, metastasis and prognosis of gastric carcinomas.
Li X; Zheng H; Hara T; Takahashi H; Masuda S; Wang Z; Yang X; Guan Y; Takano Y
Int J Oncol; 2008 Jul; 33(1):69-79. PubMed ID: 18575752
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
8. EMMPRIN expression in tongue squamous cell carcinoma.
Huang Z; Huang H; Li H; Chen W; Pan C
J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
[TBL] [Abstract][Full Text] [Related]
9. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix metalloproteinase inducer expression in salivary gland tumors: a correlation with microvessel density.
Huang ZQ; Chen WL; Li HG; Li JS; Xu ZY; Lin ZY
J Craniofac Surg; 2010 Nov; 21(6):1855-60. PubMed ID: 21119439
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
12. Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Elzagheid A; Korkeila E; Bendardaf R; Buhmeida A; Heikkilä S; Vaheri A; Syrjänen K; Pyrhönen S; Carpén O
Hum Pathol; 2008 Dec; 39(12):1737-43. PubMed ID: 18701134
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma.
Abdou AG; Sakr S; Elwahed MM; Eladly EK
Ultrastruct Pathol; 2016; 40(4):181-8. PubMed ID: 27042764
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
Won KY; Kim GY; Lim SJ; Park YK; Kim YW
Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
[TBL] [Abstract][Full Text] [Related]
15. Expression of Ezrin and phosphorylated Ezrin (pEzrin) in pancreatic ductal adenocarcinoma.
Cui Y; Li T; Zhang D; Han J
Cancer Invest; 2010 Mar; 28(3):242-7. PubMed ID: 20158339
[TBL] [Abstract][Full Text] [Related]
16. High incidence of extracellular matrix metalloproteinase inducer expression in non-small cell lung cancers. Association with clinicopathological parameters.
Hakuma N; Betsuyaku T; Kinoshita I; Itoh T; Kaga K; Kondo S; Nishimura M; Dosaka-Akita H
Oncology; 2007; 72(3-4):197-204. PubMed ID: 18160808
[TBL] [Abstract][Full Text] [Related]
17. Expression of extracellular matrix metalloproteinase inducer in odontogenic cysts.
Ali MA
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Aug; 106(2):258-63. PubMed ID: 18554952
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
19. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of fascin-1 and E-cadherin expression in laryngeal squamous cell carcinoma.
Zou J; Yang H; Chen F; Zhao H; Lin P; Zhang J; Ye H; Wang L; Liu S
Eur J Cancer Prev; 2010 Jan; 19(1):11-7. PubMed ID: 19741544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
